Shopping Cart
Remove All
Your shopping cart is currently empty
CDK4/6-IN-3, a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM), is used for the treatment of glioblastoma and inhibits CDK1 with a Ki of 110 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $4,020 | 3-6 months | 3-6 months | |
| 50 mg | $5,080 | 3-6 months | 3-6 months | |
| 100 mg | $6,800 | 3-6 months | 3-6 months |
| Description | CDK4/6-IN-3, a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM), is used for the treatment of glioblastoma and inhibits CDK1 with a Ki of 110 nM. |
| Targets&IC50 | CDK6:2.2 nM (ki), CDK1:110 nM (ki), CDK4:0.3 nM (ki) |
| In vitro | CDK4/6-IN-3 inhibits MCF7 and BT549 cell lines proliferation (EC50s: 30 nM and 2.1 μM). |
| Molecular Weight | 462.57 |
| Formula | C25H31FN8 |
| Cas No. | 2366237-37-6 |
| Smiles | C(C)N1CC2(CN(C2)C=3C=CC(NC=4N=C(C(F)=CN4)C5=C6N(N=C5)CCCC[C@H]6C)=NC3)C1 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.